Zelda Therapeutics aims to launch medicinal cannabis HOPE® range early 2020

Zelda Therapeutics Ltd (ASX:ZLD) will acquire the HOPE® range of medicinal cannabis products as part of its proposed merger with Ilera Therapeutics.

The HOPE® (HOPE 1 & 2) products were launched in Pennsylvania in May 2019 with the support of leading advocacy group HOPE Grows for Autism.

Notably, feedback from patients has consistently shown success with and acceptance of HOPE® and since its launch it has become a top-selling product in Ilera’s portfolio.

Plan is to launch early 2020

A key priority for Zelira post-merger will be to launch HOPE® into global markets from early 2020, with the aim of generating revenues in the first half of the year.

In the US, Zelira’s strategy will be to license HOPE® into multiple states using a virtual distribution model.

In ex-US markets, Zelira will leverage its existing network of suppliers and distributors to market HOPE® in different countries.

These include Germany, Australia and the UK, which together represent the fastest growing global markets.

…more to come

Story by ProactiveInvestors